Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT01082341

Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites (SPZ-Irrad)

Phase 1 and Phase 2a Clinical Trial:Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites

Sponsor: Asoclinic Inmunología Ltda.

Conditions Malaria

Interventions Immunization with P. vivax irradiated sporozoites

Updated 8 times since 2017 Last updated: Mar 21, 2018 Started: Jun 30, 2012 Primary completion: May 31, 2015 Completion: Sep 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Malaria, this trial is completed. The trial is conducted by Asoclinic Inmunología Ltda. and has accumulated 8 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

8 versions recorded

Nov 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2025 — Nov 2025 [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Apr 2018 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

Status: Active Not Recruiting → Completed
Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting PHASE1_PHASE2

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asoclinic Inmunología Ltda.
Malaria Vaccine and Drug Development Center
National Heart, Lung, and Blood Institute (NHLBI)

Data source: Malaria Vaccine and Drug Development Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cali, Colombia